VAERS reports by lot

GSK DTaP/Tdap lot F5492: VAERS reports

47 VAERS reports list lot F5492 as a GSK DTaP/Tdap vaccine, received between 2023-02-28 and 2024-12-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
47
Reports
0%
Marked serious
0
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1131%
Dermatological (non-injection-site)719%
Allergic / Anaphylactic411%
General / Systemic (non-local)411%
Respiratory38%
Gastrointestinal38%
Neurological26%
Cardiac / Cardiovascular13%
Musculoskeletal13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas6
New York6
Michigan4
Pennsylvania3
California3
Kansas2
Massachusetts2
Georgia2
Tennessee2
Kentucky2
Alabama2
Iowa1

Reports by month received

2023-021
2023-031
2023-042
2023-053
2023-061
2023-074
2023-086
2023-096
2023-105
2023-111
2024-022
2024-032
2024-043
2024-051
2024-072
2024-082
2024-103
2024-122

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.